Semnur Pharmaceuticals, Inc. (DECA)
Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023
Operating Cash Flow(3,605,000$)(2,078,488$)(69,381$)(114,131$)(1,407,000$)(2,995,336$)(114,513$)(374,151$)(158,996$)(75,664$)(157,726$)(240,397$)
Investing Cash Flow0$40,536,908$0$
Purchases of Property and Equipment
Financing Cash Flow3,540,000$10,785,783$(8,550,783$)100,000$1,406,000$3,199,300$115,000$170,700$(40,186,908$)80,000$
End Cash Position20,000$85,000$126$2,736$12,000$13,000$1,500$1,013$204,464$13,460$9,125$579,350$819,747$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow(3,605,000$)(2,078,488$)(69,381$)(114,131$)(1,407,000$)(2,995,336$)(114,513$)(374,151$)(158,996$)(75,664$)(157,726$)(240,397$)